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ABSTRACT: A major problem limiting reproducible use of
liquid extraction surface analysis (LESA) array sampling of
dried surface-deposited liquid samples is the unwanted spread
of extraction solvent beyond the dried sample limits, resulting
in unreliable data. Here, we explore the use of the Droplet
Microarray (DMA), which consists of an array of super-
hydrophilic spots bordered by a superhydrophobic material
giving the potential to conﬁne both the sample spot and the
LESA extraction solvent in a deﬁned area. We investigated the
DMA method in comparison with a standard glass substrate
using LESA analysis of a mixture of biologically relevant
compounds with a wide mass range and diﬀerent phys-
icochemical properties. The optimized DMA method was subsequently applied to urine samples from a human intervention
study. Relative standard deviations for the signal intensities were all reduced at least 3-fold when performing LESA-MS on the
DMA surface compared with a standard glass surface. Principal component analysis revealed more tight clusters indicating
improved spectral reproducibility for a human urine sample extracted from the DMA compared to glass. Lastly, in urine samples
from an intervention study, more signiﬁcant ions (145) were identiﬁed when using LESA-MS spectra of control and test urine
extracted from the DMA. We demonstrate that DMA provides a surface-assisted LESA-MS method delivering signiﬁcant
improvement of the surface extraction repeatability leading to the acquisition of more robust and higher quality data. The DMA
shows potential to be used for LESA-MS for controlled and reproducible surface extraction and for acquisition of high quality,
qualitative data in a high-throughput manner.
L iquid extraction surface analysis−mass spectrometry(LESA-MS) is an ambient mass spectrometry technique
in which analytes are extracted from a surface by the formation
of a liquid microjunction between the extraction solvent and
the surface.1 This technique has already been widely applied for
the analysis of proteins,2 metabolites,3 drugs,3 and lipids4 in a
wide range of matrices and on various surface substrates. One
of the main limitations of LESA-MS is poor repetitive sampling
due to spreading of the probe solvent on the surface of
interest.4 Irregular spreading of the extraction solvent can
potentially lead to poor reproducibility of the reaspirated
solvent volume4 and therefore may introduce undesired
variance between spectra. A number of groups have limited
the spreading of the probe solvent by using electrodes5 or
applying pressure on top of the solvent.4 Another way of
limiting solvent spread is contact LESA6 or performing laser
ablation rather than liquid extraction.7
It already has been observed that the spreading of the
extraction solvent on hydrophilic surfaces is substantial6 and
that the use of nonpolar solvents such as chloroform
dramatically increases the solvent spread.4 When the surface
itself is not part of the system and is simply there to support a
spot of liquid analyte, the analytical performance of liquid
surface sampling could be enhanced by the judicious choice of
the surface properties to vastly improve spatial conﬁnement of
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both sample deposition and the application of extraction
solvent. Van Berkel et al. reported a reproducibility ranging
between 10% and 34% for diﬀerent lysozyme concentrations on
Teﬂon-masked microscope slides analyzed by a continuous
surface sampling probe.8
Hence, repeatable probe solvent recovery as well as
extraction eﬃciency could be optimized by designing a
substrate surface, which conﬁnes both the liquid sample and
the LESA extraction solvent within a consistent area. We
propose that these requirements can be met by using a platform
for high-throughput cell screening called the Droplet Micro-
array (DMA; http://www.aquarray.com/). The DMA consists
of multiple superhydrophilic spots bordered by a super-
hydrophobic material produced by chemically modifying a
polymer surface.9,10 These surface properties are of interest for
LESA to assist in obtaining reproducible analyte spot
deposition and extraction solvent coverage of the spots. The
superhydrophilic part guides the solvent along the surface while
the superhydrophobic material has a low surface tension and is
therefore diﬃcult to wet.11 This will limit the deposited sample
as well as the extraction solvent from further spreading. Besides
the surface chemistry, the use of the DMA for LESA is of
interest due to its high-throughput design. Here, we compare
the DMA high-throughput array to a standard glass microscope
slide, which is often used as a substrate for LESA-MS,3,4,7,12−22
to test the hypothesis that conﬁning the sample as well as the
extraction solvent in a deﬁned area assists in obtaining
repeatable solvent recovery leading to improved spectral
reproducibility and multivariate modeling.
■ MATERIALS AND METHODS
Chemicals. Methanol, formic acid, and water were all
purchased as MS grade (CHROMASOLV) from Sigma-Aldrich
(Gillingham, UK). Taurine, diphenhydramine HCl, and
Rhodamine 6G were purchased from Acros Organics (Geel,
Belgium). L-Arginine, raﬃnose pentahydrate, hemin, and
vitamin B12 were bought at Sigma-Aldrich (Gillingham, UK).
Sodium hydroxide was purchased from VWR International
(Leuven, Belgium).
Sample Preparation. Standard Mixture. Individual stock
solutions of taurine, L-arginine, diphenhydramine, Rhodamine
6G, raﬃnose (all 10 mM), and vitamin B12 (1 mM) were
freshly prepared in deionized water (18.2 MΩ; ELGA
PureLab). A 10 mM stock solution of hemin was prepared in
50 mM NaOH. A mixture containing all standards was created
with a working concentration of 10 μM in deionized water for
all compounds. Ten spots of 2 μL of standard mixture were
manually pipetted onto the DMA (2.8 mm hydrophilic circular
spots, 1.7 mm superhydrophobic borders; Aquarray, Karlsruhe,
Germany; Supplementary File 1) as well as a glass slide and
allowed to air dry.
Urine Samples. The study design was authorized by
University of Nottingham Ethical Committee of the School
of Pharmacy, University of Nottingham (reference number:
021-2016). Control urine was collected without the use of
preservatives from four healthy male volunteers prior to tea
consumption. Then, the same volunteers consumed 200 mL of
brewed Earl Gray tea with water (Twinings, R. Twining &
Company Limited, UK). Urine samples were collected 2 h after
consumption and stored immediately in a −80 °C freezer. All
urine samples were thawed on ice and then brieﬂy vortexed.
Urine samples were manually pipetted (2 μL) on individual
superhydrophilic spots as well as onto a clean glass slide.
Samples were allowed to air dry prior to analysis.
Liquid Extraction Surface Analysis−Mass Spectrome-
try (LESA-MS). A LESA extraction solvent was prepared
containing methanol, water, and formic acid in a volume ratio
of, respectively, 70:30:0.1.3 Slides were placed onto the LESA
universal plate holder and scanned with an Epson V300
scanner, and coordinates of sample locations were selected with
LESA Points software (Advion Biosciences, Inc., Ithaca, USA).
After that, LESA was performed using the TriVersa Nanomate
(Advion Biosciences, Inc., Ithaca, USA). The extraction solvent
(5 μL) was aspirated from the solvent reservoir from which 3
μL was dispensed onto the substrate surface. After 5 s, 3.5 μL
was re-aspirated into the tip and, after a delay of 10 s, the tip
was directed to a nanoESI chip. Ionization was performed at
1.45 kV with 0.3 psi back pressure.3 Data was acquired for 1.5
min in electrospray positive ionization mode on an Exactive
Orbitrap mass spectrometer (Thermo Scientiﬁc, San Jose,
USA) using a scan range of m/z 100−1500. The resolution was
set to 100 000 at m/z 400. Maximum injection was set to 1000
ms; the AGC target was set to 1 × 106, and every scan consisted
of 1 microscan. The capillary temperature was set to 250 °C,
and the declustering potential, skimmer voltage, and capillary
voltage were, respectively, set to 125, 20, and 80 V.
Data Analysis. Average scans were generated in Xcalibur
v2.1 (Thermo Scientiﬁc, San Jose, USA) and exported as .RAW
ﬁles. These ﬁles were converted to .mzXML ﬁles using
ProteoWizard (http://proteowizard.sourceforge.net/). Con-
verted ﬁles were further processed using a combination of
SpectralAnalysis23 and an in-house MATLAB script (R2016b,
The MathWorks, Inc.).
For the standard mixture, signal intensities of the most
abundant adduct ion were selected, log transformed, and
normalized using the ratio of the sample’s total ion count
(TIC) and the class TIC average. Relative standard deviations
(RSD) of the signal intensity were calculated per standard for
both surfaces and statistically compared using Forkman’s F-
test24 (α = 0.05).
For the urine samples, spectral data were background
subtracted and Savitzky-Golay smoothed,25 and a correction
was applied for signal intensity loss due to smoothing by
multiplying the smoothed data with a factor. This multi-
plication factor was calculated by taking the ratio of the original
base peak intensity and the smoothed base peak intensity (see
Supplementary File 2 for an example). Subsequently, spectra
were log transformed and TIC normalized. Spectral reprodu-
cibility was checked using peaks with an 80% detection rate26
(threshold intensity: 1 × 103) within all analytical replicates (n
= 5) of a control urine sample.
Metabolic proﬁling was done using the same preprocessing
steps except peaks were only included at a class detection rate
of 75%. Missing values were replaced by using mean
imputation27 per class. After preprocessing, counting of unique
and signiﬁcant ions between classes was performed. Compar-
ison of TIC normalized peak intensities was done using
Student’s t test at a signiﬁcance level of 0.05, and p-values were
corrected on the basis of a false discovery rate (FDR) using the
Benjamini-Hochberg procedure.28 After, the data were Pareto
scaled29 and subjected to principal component analysis (PCA).
■ RESULTS AND DISCUSSION
Extraction Repeatability and Spectral Reproducibility.
Ten dried spots of standard analyte mixture on glass and DMA
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were analyzed using LESA-MS, and RSDs were calculated for
the most abundant adduct ion for each standard (Table 1). All
RSDs were below 8% when extracted from the DMA while
extraction from glass resulted in RSDs above 20% which is
higher than the limit of the acceptable precision (15%) for an
analytical method.30
Analytical replicates of a human urine control sample (n = 5)
were dispensed at ﬁve locations on glass as well as on ﬁve DMA
spots, and the dried urine spots were analyzed with LESA-MS
(Supplementary File 3). Data were subjected to peak picking
(≥80% detection rate) and subsequently normalized to the
TIC and log transformed to compare the deviations per peak
intensity between both surfaces. It was observed that the RSD
for each ion was reduced (Supplementary File 3), indicating
better spectral reproducibility using the DMA as a substrate
compared with glass. The high degree of spectral similarity
between replicate samples can be related to the conﬁnement of
both the sample and the extraction solvent within a deﬁned
area (Figure 1), which increases the extraction repeatability.
The superhydrophilic spots allow increased wetting of the
surface,31 thus improving analyte deposition uniformity and
resulting in increased LESA solvent extraction eﬃciency.
Further, conﬁning the extraction solvent within a deﬁned area
would be expected to result in a more stable microjunction
formed between the tip and surface and hence explain the
improved analytical performance. Therefore, the use of the
Table 1. Comparison of Relative Standard Deviations of Signal Intensities per Compound between Glass and DMA
compound adduct m/z RSD glass (%) RSD DMA (%) p-value
Taurine [M + Na]+ 148.0044 25.3 7.6 0.015
L-Arginine [M + Na]+ 197.1015 23.1 7.3 0.020
Diphenhydramine [M + H]+ 256.1701 20.1 5.1 4.0 × 10−4
Rhodamine 6G [M − Cl]+ 443.2335 20.0 5.1 4.3 × 10−4
Raﬃnose [M + Na]+ 527.1588 21.7 7.4 0.0034
Hemin [M − Cl]+ 616.1773 21.4 5.6 7.7 × 10−4
Vitamin B12 [M + 2Na]+ 700.2735 26.6 7.9 0.0056
Figure 1. Depositing and extraction of samples from the Droplet Microarray and glass surface. (a) 10 mM hemin in 50 mM NaOH manually
pipetted onto glass (top) and Droplet Microarray (bottom). Sample volume: 3 μL; spot size DMA: ∼2.8 mm; spot size glass: ∼4.0 mm. (b)
Microscope image (Optical Proﬁle, Zeta Instruments; 5× magniﬁcation) of dried urine on Droplet Microarray (left) and glass (right). Images taken
before (top) and after extraction (bottom). Visually higher eﬃcient extraction from DMA. Sample volume: 2 μL.
Figure 2. Volcano plots for common ions between urine samples before and after tea consumption. (a) Urine extracted from glass. (b) Urine
extracted from DMA. Green and red data points indicate ions, which are, respectively, increasing and decreasing signiﬁcantly (p < 0.05) and at least
2-fold in intensity.
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DMA with hydrophilic spots permits longer extraction times
without the loss of solvent, with a beneﬁt for enhancing the
extraction eﬃciency.32
Metabolic Proﬁling. Control (n = 4) and tea consumers’
(n = 4) urine samples were spotted onto glass and the DMA
and, after drying, subjected to LESA-MS analysis. The collected
spectra were analyzed in MATLAB. On average, 544 and 1343
features were found in the urine samples before and after tea
consumption on the DMA, respectively. In contrast, LESA-MS
analysis of urine before and after tea consumption on a glass
surface resulted in, respectively, 941 and 806 features on
average. At a 75% class detection rate, more unique ions were
found in urine after tea consumption using the DMA (n = 340)
as substrate compared to glass (n = 12). A total of 395 and 453
common ions were found between urine samples before and
after tea consumption on DMA and glass, respectively. Peak
intensities were compared using a Student’s t test (α = 0.05),
and p-values were FDR corrected. This resulted in 163
signiﬁcant ions for urine samples extracted from the DMA
while only 18 signiﬁcant ions were found when glass was used
as substrate (Figure 2). Subjecting the data to PCA after TIC
normalization and Pareto scaling showed better clustering for
the control samples in the scores plot when the DMA was used
as substrate (R2: 0.9609; Q2: 0.8938; Figure 3). In contrast, the
scores plot for data acquired from glass showed no separation
between the urine groups (R2: 0.7184; Q2: −0.1551). Again, the
substantial increase of the number of signiﬁcant ions as well as
the improvement in multivariate modeling can be related to
enhanced reproducibility of the solvent recovery and extraction
eﬃciency. These ﬁndings show potential of using the DMA in
combination with LESA-MS as an alternative to conventional
methods for proﬁling of biological samples. Compared to direct
infusion MS, ion suppression due to a high nonvolatile salt
content in a biological sample33 could be reduced due to the
dilution eﬀect of the sample in the LESA extraction solvent.
Further, the reduced run time and solvent consumption could
favor LESA-MS over liquid chromatography−mass spectrom-
etry (LC-MS).
■ CONCLUSION
We demonstrate that the DMA surface has signiﬁcant
advantages for consistent, high-throughput LESA-MS analysis,
which we attribute to the superhydrophilic−superhydrophobic
array patterning. We found that the speciﬁc DMA surface
properties improved extraction repeatability and spectral
reproducibility resulting in higher quality metabolic proﬁling.
This can be of use for cost-eﬀective and fast clinical screening/
proﬁling of human clinical samples such as body ﬂuids (e.g.,
Figure 3. PCA scores and loadings plot for ions (≥75% class detection) found in urine before (green) and after tea consumption (yellow) extracted
from (a) glass (R2: 0.7184; Q2: −0.1551) and (b) DMA (R2: 0.9609; Q2: 0.8938). Data was TIC normalized and Pareto scaled.
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urine, blood). Moreover, increased sampling and spectral
reproducibility could provide opportunities for improved
quantitative analysis when suitable internal standards are
available. In addition, the extraction solvent is conﬁned within
the sample area, which allows extended extraction times and
provides potential beneﬁts for the analysis of poorly soluble
compounds. In conclusion, the DMA shows a huge potential
for cost-eﬀective and robust high-throughput screening/
proﬁling of liquid matrices using LESA-MS, since only small
volumes of sample and extraction solvent are required.
Furthermore, there is no risk of cross contamination during
sampling and extraction, and sample data can be acquired,
depending on solubility, within a short time interval.
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(16) Tomlinson, L.; Fuchser, J.; Fütterer, A.; Baumert, M.; Hassall, D.
G.; West, A.; Marshall, P. S. Rapid Commun. Mass Spectrom. 2014, 28
(9), 995−1003.
(17) Sarsby, J.; Martin, N. J.; Lalor, P. F.; Bunch, J.; Cooper, H. J. J.
Am. Soc. Mass Spectrom. 2014, 25 (11), 1953−1961.
(18) Griffiths, R. L.; Cooper, H. J. Anal. Chem. 2016, 88 (1), 606−
609.
(19) Eikel, D.; Vavrek, M.; Smith, S.; Bason, C.; Yeh, S.; Korfmacher,
W. A.; Henion, J. D. Rapid Commun. Mass Spectrom. 2011, 25 (23),
3587−3596.
(20) Hall, Z.; Ament, Z.; Wilson, C. H.; Burkhart, D. L.; Ashmore,
T.; Koulman, A.; Littlewood, T.; Evan, G. I.; Griffin, J. L. Cancer Res.
2016, 76 (16), 4608−4618.
(21) Griffiths, R. L.; Creese, A. J.; Race, A. M.; Bunch, J.; Cooper, H.
J. Anal. Chem. 2016, 88 (13), 6758−6766.
(22) Hall, Z.; Chu, Y.; Griffin, J. L. Anal. Chem. 2017, 89 (9), 5161−
5170.
(23) Race, A. M.; Palmer, A. D.; Dexter, A.; Steven, R. T.; Styles, I.
B.; Bunch, J. Anal. Chem. 2016, 88 (19), 9451−9458.
(24) Forkman, J. Commun. Stat. - Theory Methods 2009, 38 (2), 233−
251.
(25) Savitzky, A.; Golay, M. J. Anal. Chem. 1964, 36 (8), 1627−1639.
(26) Yang, J.; Zhao, X.; Lu, X.; Lin, X.; Xu, G. Front. Mol. Biosci.
2015, 2 (4), 1−9.
(27) Dray, S.; Josse, J. Plant Ecol. 2015, 216 (5), 657−667.
(28) Benjamini, Y.; Hochberg, Y. J. R. Stat. Soc. Ser. B 1995, 57 (1),
289−300.
(29) van den Berg, R. A.; Hoefsloot, H. C.; Westerhuis, J. A.; Smilde,
A. K.; van der Werf, M. J. BMC Genomics 2006, 7 (1), 142.
(30) Hartmann, C.; Smeyers-Verbeke, J.; Massart, D.; McDowall, R.
J. Pharm. Biomed. Anal. 1998, 17 (2), 193−218.
(31) Drelich, J.; Chibowski, E. Langmuir 2010, 26 (24), 18621−
18623.
(32) Van Berkel, G. J.; Kertesz, V. Rapid Commun. Mass Spectrom.
2013, 27 (12), 1329−1334.
(33) Clarke, D. J.; Campopiano, D. J. Analyst 2015, 140 (8), 2679−
2686.
Analytical Chemistry Technical Note
DOI: 10.1021/acs.analchem.8b00973
Anal. Chem. 2018, 90, 6001−6005
6005
